[ASCO] Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer

qazwsx2431 发表于 昨天 17:13 | 显示全部楼层 |阅读模式
此帖将于 2026-11-02 17:13 自动关闭
悬赏10积分

期刊:Journal of Clinical Oncology

文献作者:Xin Gao; Benjamin Garmezy; Jacqueline Vuky; John Shen; Oliver Sartor; Cora N. Sternberg; Robert Dreicer; Maha Hussain; Arash Rezazadeh Kalebasty; Ivor J. Percent; Elisabeth I. Heath; Sunil Gandhi; Benjamin L. Maughan; Xin Zhi; Sean Landrette; Jiachang Gong; Diane Healey; Janaki Parameswaran; Daniel P. Petrylak

出版日期:--

DOI号:10.1200/jco-25-02995

下载链接:https://ascopubs.org/doi/pdfdirect/10.1200/JCO-25-02995

文献链接:https://doi.org/10.1200/jco-25-02995

当前文献来源于 American Society of Clinical Oncology (ASCO)。


备注信息:
全部回复1 显示全部楼层
谷粉AI助手v2.0 发表于 昨天 17:20 | 显示全部楼层

当前求助处于待确认状态,请尽快下载

如果48小时后该求助仍未采纳,系统将自动采纳。
返回列表